A clinical study NERUNJI VER KUDINEER for KALLADAIPPU[Urolithiasis]

Phase 2

Not yet recruiting

• Conditions: KALLADAIPPU

• Registration Number: CTRI/2018/03/012710
• Lead Sponsor: Dr S Neelavathi MD PhD

Brief Summary

The study is A Prospective Open Labelled   Non Randomized clinical study to evaluate the therapeutic efficacy of NERUNJI VER KUDINEER 100ml BD for30 days in 40 patients during the trial period of 15 months that will be conducted in Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug NERUNJI VER KUDINEER in KALLADAIPPU The secondry outcome will be the evaluation of Siddha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drug

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-04
• Last Update Posted: 2018-03-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age from 30 years to 60 years Patient With Renal Colicky pain Nausea Vomiting Haematuria Oliguria Pyuria Dysuria.

Exclusion Criteria

Age Below 30 years and above 60 years Chronic Appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes Mellitus Metabolic disorders like Hyperthyroidism Hyperparathyroidism Pelvic Inflammatory Disease Chronic Renal Failure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Therapeutic efficacy of taial drug NERUNJI VER KUDINEER in KALLADAIPPU	30 days

Secondary Outcome Measures

Name	Time	Method
Evaluation of Sidhha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drug	30 days

Trial Locations

Locations (1)

Govt Siddha Medical College And Hospital; 🇮🇳 Tirunelveli, TAMIL NADU, India

Govt Siddha Medical College And Hospital

🇮🇳Tirunelveli, TAMIL NADU, India

Bernath P

Principal investigator

9486805805

dr.a.bernath@gmail.com